Vigilant Capital Management’s Pfizer PFE Stock Holding History

Vigilant Capital Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$3.07M	Sell	83,759 -500	-0.6%	-$19.5K	0.23%	46
2023 Q1	$3.44M	Sell	84,259 -150	-0.2%	-$6.48K	0.28%	46
2022 Q4	$4.33M	Sell	84,409 -557	-0.7%	-$26.7K	0.37%	45
2022 Q3	$3.72M	Buy	84,966 +528	+0.6%	+$25.7K	0.35%	46
2022 Q2	$4.43M	Sell	84,438 -3,279	-4%	-$167K	0.38%	48
2022 Q1	$4.54M	Sell	87,717 -1,906	-2%	-$98.9K	0.35%	47
2021 Q4	$5.29M	Buy	89,623 +3,709	+4%	+$184K	0.37%	50
2021 Q3	$3.69M	Sell	85,914 -2,654	-3%	-$118K	0.3%	51
2021 Q2	$3.47M	Buy	88,568 +1,202	+1%	+$46.7K	0.28%	50
2021 Q1	$3.17M	Sell	87,366 -1,116	-1%	-$39.6K	0.28%	49
2020 Q4	$3.26M	Sell	88,482 -6,884	-7%	-$253K	0.31%	47
2020 Q3	$3.32M	Buy	95,366 +4,701	+5%	+$165K	0.36%	45
2020 Q2	$2.81M	Buy	90,665 +1,686	+2%	+$57.3K	0.34%	44
2020 Q1	$2.75M	Sell	88,979 -5,978	-6%	-$204K	0.4%	47
2019 Q4	$3.53M	Buy	94,957 +1,792	+2%	+$63.8K	0.41%	48
2019 Q3	$3.18M	Sell	93,165 -9,111	-9%	-$331K	0.41%	46
2019 Q2	$4.2M	Sell	102,276 -3,010	-3%	-$120K	0.56%	45
2019 Q1	$4.24M	Sell	105,286 -3,001	-3%	-$120K	0.59%	45
2018 Q4	$4.49M	Sell	108,287 -20,042	-16%	-$832K	0.71%	43
2018 Q3	$5.37M	Sell	128,329 -1,142	-0.9%	-$44K	0.72%	42
2018 Q2	$4.46M	Sell	129,471 -3,892	-3%	-$133K	0.65%	43
2018 Q1	$4.49M	Buy	133,363 +75,459	+130%	+$2.59M	0.64%	42
2017 Q4	$1.99M	Buy	57,904 +16,754	+41%	+$571K	0.26%	63
2017 Q3	$1.39M	Sell	41,150 -1,511	-4%	-$48.6K	0.21%	64
2017 Q2	$1.36M	Sell	42,661 -725	-2%	-$22.9K	0.22%	66
2017 Q1	$1.41M	Sell	43,386 -3,493	-7%	-$110K	0.25%	66
2016 Q4	$1.45M	Sell	46,879 -1,767	-4%	-$53.9K	0.25%	66
2016 Q3	$1.56M	Sell	48,646 -2,550	-5%	-$85.3K	0.28%	66
2016 Q2	$1.71M	Sell	51,196 -2,126	-4%	-$67.9K	0.33%	63
2016 Q1	$1.5M	Sell	53,322 -1,880	-3%	-$53.7K	0.3%	62
2015 Q4	$1.69M	Sell	55,202 -2,108	-4%	-$66.3K	0.34%	60
2015 Q3	$1.71M	Buy	57,310 +1,930	+3%	+$61.9K	0.34%	59
2015 Q2	$1.76M	Buy	55,380 +527	+1%	+$17.2K	0.32%	61
2015 Q1	$1.81M	Sell	54,853 -110	-0.2%	-$3.5K	0.34%	60
2014 Q4	$1.62M	Sell	54,963 -1,186	-2%	-$34K	0.32%	66
2014 Q3	$1.57M	Sell	56,149 -196	-0.3%	-$5.5K	0.34%	57
2014 Q2	$1.59M	Sell	56,345 -6,524	-10%	-$186K	0.35%	56
2014 Q1	$1.92M	Sell	62,869 -6,508	-9%	-$194K	0.45%	55
2013 Q4	$2.02M	Sell	69,377 -1,717	-2%	-$50K	0.49%	51
2013 Q3	$1.94M	Hold	71,094	–	–	0.55%	50
2013 Q2	$1.89M	Buy	+71,094	New	+$1.96M	0.56%	53

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Vigilant Capital Management's PFE Position: Q2 2023 in Review

Vigilant Capital Management reduced its Pfizer (PFE) stake by 0.59% in Q2 2023, selling an estimated $19.5K and leaving 83,759 shares worth $3.07M. The position accounts for 0.23% of the portfolio, ranked #46.

Vigilant Capital Management first reported a position in PFE in Q2 2013 and has held it in 41 quarters since. The position peaked at $5.37M in Q3 2018. 3,041 funds tracked by Wall St. Rank hold PFE as of Q2 2023.

Vigilant Capital Management held 83,759 shares of Pfizer worth $3.07M as of Q2 2023.
Vigilant Capital Management sold 500 Pfizer shares in Q2 2023, an estimated $19.5K.
Pfizer made up 0.23% of Vigilant Capital Management's portfolio in Q2 2023, its #46 holding.
Vigilant Capital Management first reported a position in Pfizer in Q2 2013 and has held it in 41 quarters since.
Vigilant Capital Management's Pfizer position peaked at $5.37M in Q3 2018.
3,041 funds tracked by Wall St. Rank held Pfizer as of Q2 2023.

Based on Vigilant Capital Management's 13F filing for Q2 2023, filed 8 Aug 2023.